
Join to view full profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Kalemkerian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1985 - 1989
Northwestern University The Feinberg School of MedicineClass of 1985
Certifications & Licensure
MI State Medical License 1993 - 2027
MD State Medical License 1989 - 1994
IL State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 4 citationsFinal Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With AdvancedFusion-Positive Non-Small Cell Lung Cancer.Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano, Daniel W Bowles, Robert C Doebele
Journal of Clinical Oncology. 2026-05-01 - 1 citationsPembrolizumab in Combination With Platinum-Based Chemotherapy in Patients With Recurrent EGFR and ALK Gene Altered Non-Small-Cell Lung Cancer (NSCLC).Shirish M Gadgeel, Misako Nagasaka, Karen Dziubek, Thomas Braun, Khaled Hassan
Clinical Lung Cancer. 2026-03-01 - The Art of the Art of Oncology.Mikkael A Sekeres, Gregory A Abel, Timothy Gilligan, Stephanie L Graff, Gregory P Kalemkerian
Journal of Clinical Oncology. 2025-08-20
Journal Articles
- The EGFR T790M Mutation Is Acquired Through AICDA-Mediated Deamination of 5-Methylcytosine Following TKI Treatment in Lung CancerGregory P Kalemkerian, Khaled A Hassan, Clinical Cancer Research
Other
- Chemoradiotherapy for the initial treatment of limited stage small cell lung cancerKalemkerian GP, Baldini EH
http://www.uptodate.com/contents/chemoradiotherapy-for-the-initial-treatment-of-limited-stage-small-
UpToDate, Wolters Kluwer Health - 2013-03-18
Press Mentions
Sixteen Individuals, and Members of Comprehensive Stroke Program, Honored with Faculty and Staff AwardsDecember 13th, 2024
How Hollywood May Make Oncologists’ Jobs HarderFebruary 7th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: